Roivant Sciences Ltd. (ROIV) Tops Q1 EPS by 36c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q1 EPS of $0.12, $0.36 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $55.13 million versus the consensus estimate of $30.84 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Active options: META PLTR META SMCI MU SOFI GOOG NOK MSTR AVGO AMD HOOD
• Texas AG Paxton announces ongoing investigation into Carnival over data breach